Strategic partnerships CTPharma has a history of collaborating with reputable institutions such as Yale University School of Medicine and Saba University School of Medicine to study cannabis-derived treatments, presenting opportunities to offer research collaborations, clinical trial support, or co-developed product formulations.

Expansion footprint With a significant footprint expansion in Rocky Hill and a large cultivation/production facility, CTPharma could benefit from enhanced supply chain services, wholesale distribution partnerships, and packaging or logistics optimization for increased product lines.

Innovative products Recent launches like RSO chocolate signal openness to novel, consumer-friendly formats. Sales teams can explore cross-category partnerships, regulatory-compliant novelty products, and targeted marketing to medical and adult-use segments.

Clinical collaboration Ongoing clinical research with Yale and UConn indicates a readiness to engage in sponsored studies or pharmacovigilance programs. There are opportunities to license data access, support evidence generation, and align with payer-focused outcomes.

Quality and compliance ISO 9001 and a tech stack emphasizing quality management (ERP/Sage/Epicor) suggest a durable framework for enterprise customers needing compliant, traceable cannabis-derived medicines, enabling BD pitches around audits, certification readiness, and partner-grade supply.